These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1327802)
1. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Stuber G; Modrow S; Höglund P; Franksson L; Elvin J; Wolf H; Kärre K; Klein G Eur J Immunol; 1992 Oct; 22(10):2697-703. PubMed ID: 1327802 [TBL] [Abstract][Full Text] [Related]
2. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1. Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988 [TBL] [Abstract][Full Text] [Related]
3. A quantitative assay of peptide-dependent class I assembly. Elvin J; Cerundolo V; Elliott T; Townsend A Eur J Immunol; 1991 Sep; 21(9):2025-31. PubMed ID: 1909640 [TBL] [Abstract][Full Text] [Related]
4. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells. Murray RJ; Brooks JM; Rickinson AB; Rowe M Eur J Immunol; 1990 Mar; 20(3):659-64. PubMed ID: 1690661 [TBL] [Abstract][Full Text] [Related]
5. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811 [TBL] [Abstract][Full Text] [Related]
6. High occupancy binding of antigenic peptides to purified, immunoadsorbed H-2Db beta 2m molecules. Burshtyn DN; Barber BH J Immunol; 1993 Sep; 151(6):3070-81. PubMed ID: 8397250 [TBL] [Abstract][Full Text] [Related]
7. HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein. Choppin J; Martinon F; Connan F; Gomard E; Levy JP J Immunol; 1991 Jul; 147(2):569-74. PubMed ID: 1712811 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization. Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413 [TBL] [Abstract][Full Text] [Related]
9. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693 [TBL] [Abstract][Full Text] [Related]
10. Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules. Sette A; Vitiello A; Farness P; Furze J; Sidney J; Claverie JM; Grey HM; Chesnut R J Immunol; 1991 Dec; 147(11):3893-900. PubMed ID: 1658152 [TBL] [Abstract][Full Text] [Related]
11. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes. Ogg GS; Dunbar PR; Cerundolo V; McMichael AJ; Lemoine NR; Savage P Br J Cancer; 2000 Mar; 82(5):1058-62. PubMed ID: 10737389 [TBL] [Abstract][Full Text] [Related]
12. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. Stuber G; Leder GH; Storkus WT; Lotze MT; Modrow S; Székely L; Wolf H; Klein E; Kärre K; Klein G Eur J Immunol; 1994 Mar; 24(3):765-8. PubMed ID: 8125143 [TBL] [Abstract][Full Text] [Related]
13. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201 [TBL] [Abstract][Full Text] [Related]
14. Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I molecules: studies in antigen-processing defective cell lines. Cullis JO; Barrett AJ; Goldman JM; Lechler RI Leukemia; 1994 Jan; 8(1):165-70. PubMed ID: 8289483 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397 [TBL] [Abstract][Full Text] [Related]
16. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells. Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044 [TBL] [Abstract][Full Text] [Related]
17. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Wei ML; Cresswell P Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127 [TBL] [Abstract][Full Text] [Related]
18. Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7. Hill A; Worth A; Elliott T; Rowland-Jones S; Brooks J; Rickinson A; McMichael A Eur J Immunol; 1995 Jan; 25(1):18-24. PubMed ID: 7531143 [TBL] [Abstract][Full Text] [Related]
19. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Gotch F; Rothbard J; Howland K; Townsend A; McMichael A Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]